Patlak重建动态18F-FDG PET显像评估恶性肝脏肿瘤:肝细胞癌、肝内胆管癌与转移性肝肿瘤的比较
本研究纳入71例肝内胆管癌、转移性肝肿瘤或肝细胞癌患者,行动态全身及静态双时间点FDG PET/CT,分析FDG代谢率(MR FDG)与游离FDG分布容积(DV FDG)同静态参数的相关性,并按肿瘤类型比较。结果显示MR FDG与SUV相关性良好,肝细胞癌MR FDG和DV FDG显著低于肝内胆管癌和转移性肝肿瘤,MR FDG鉴别肝细胞癌与后两者的曲线下面积分别为0.84和0.80。
要点
- MR FDG与早期及延迟SUVmax相关性良好(r=0.71~0.97),肝细胞癌DV FDG相关性较低(r=0.62和0.69)。
- 肝细胞癌MR FDG(2.43±1.98)和DV FDG(139.95±62.58)显著低于肝内胆管癌和转移性肝肿瘤。
- MR FDG鉴别肝细胞癌与肝内胆管癌、转移性肝肿瘤的曲线下面积分别为0.84和0.80。
核心结论
- MR FDG在三种恶性肿瘤中与SUVmax强相关,并显示出鉴别肝细胞癌与肝内胆管癌及转移性肝肿瘤的效用。
- 每种肿瘤类型具有不同的葡萄糖代谢,动态全身FDG PET/CT有潜力显示这些差异。
研究设计与样本
- 纳入71例肝内胆管癌、转移性肝肿瘤或肝细胞癌患者,行动态全身及静态双时间点FDG PET/CT。
- 共分析12个肝内胆管癌、116个转移性肝肿瘤和36个肝细胞癌病灶。
- 计算MR FDG(mg/min/100ml)或DV FDG(%)与静态PET/CT参数的Pearson相关系数,并按肿瘤类型比较MR FDG和DV FDG,对MR FDG和静态图像行受试者工作特征分析。
主要发现
- MR FDG和DV FDG与早期SUV(SUVe)及延迟SUVmax(SUVd)相关性优秀(r=0.71~0.97),但肝细胞癌病灶中DV FDG与SUVe及SUVd的r分别为0.62和0.69(P<0.001)。
- 肝细胞癌病灶MR FDG(2.43±1.98)和DV FDG(139.95±62.58)显著低于肝内胆管癌(5.02±3.56,207.06±97.13)和转移性肝肿瘤病灶(4.51±2.47,180.13±75.58)(P均<0.01)。
- 最佳MR FDG鉴别肝细胞癌与肝内胆管癌的曲线下面积为0.84,鉴别肝细胞癌与转移性肝肿瘤的曲线下面积为0.80。
- 转移性肝肿瘤病灶的MR FDG和DV FDG值分布最宽,但大多数原发部位间无显著差异。
关键数值与推荐
- MR FDG单位为mg/min/100ml,DV FDG单位为%。
- 肝细胞癌MR FDG 2.43±1.98、DV FDG 139.95±62.58;肝内胆管癌MR FDG 5.02±3.56、DV FDG 207.06±97.13;转移性肝肿瘤MR FDG 4.51±2.47、DV FDG 180.13±75.58。
- MR FDG鉴别肝细胞癌与肝内胆管癌的曲线下面积为0.84,鉴别肝细胞癌与转移性肝肿瘤的曲线下面积为0.80。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE OF THE REPORT: The aim of this study was to explore the different patterns of dynamic whole-body (D-WB) FDG PET/CT parameters among liver malignancy types as potential diagnostic clues and investigate the association between static and dynamic PET/CT parameters for each tumor histology. PATIENTS AND METHODS: Seventy-one patients with intrahepatic cholangiocarcinoma (ICC), metastatic liver tumor (MLT), or hepatocellular carcinoma (HCC) who underwent D-WB and static dual-time-point FDG PET/CT were enrolled. We obtained Pearson correlation coefficients between the metabolic rate of FDG (MR FDG ; mg/min/ 100ml) or distribution volume of free FDG (DV FDG , %) and static PET/CT parameters. We compared MR FDG and DV FDG values by tumor type and performed receiver operating characteristic analyses for MR FDG and static images. RESULTS: A total of 12 ICC, 116 MLT, and 36 HCC lesions were analyzed. MR FDG and DV FDG showed excellent correlation with early (SUV e ) and delayed SUV max (SUV d ) ( r = 0.71~0.97), but DV FDG in the HCC lesions did not ( r = 0.62 and 0.69 for SUV e and SUV d , respectively) ( P < 0.001 for all). HCC lesions showed significantly lower MR FDG (2.43 ± 1.98) and DV FDG (139.95 ± 62.58) than ICC (5.02 ± 3.56, 207.06 ± 97.13) and MLT lesions (4.51 ± 2.47, 180.13 ± 75.58) ( P < 0.01 for all). The optimal MR FDG could differentiate HCC from ICC and MLT with areas under the curve of 0.84 and 0.80, respectively. Metastatic liver tumor lesions showed the widest distribution of MR FDG and DV FDG values but with no significant difference among most primary sites. CONCLUSIONS: MR FDG was strongly correlated with SUV max in the 3 malignancies and showed utility for differentiating HCC from ICC and MLT. Each tumor type has a different glucose metabolism, and D-WB FDG PET/CT imaging has the potential to visualize those differences.
引用
- Kaneko K, Nagao M, Yamamoto A, et al. Patlak Reconstruction Using Dynamic 18 F-FDG PET Imaging for Evaluation of Malignant Liver Tumors : A Comparison of HCC, ICC, and Metastatic Liver Tumors. Clin Nucl Med. 2023. PMID: 38108830. doi:10.1097/RLU.0000000000005013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。